Maintenance rituximab or observation after frontline treatment with bendamustine‐rituximab for follicular lymphoma
Sign Up to like & getrecommendations! Published in 2019 at "British Journal of Haematology"
DOI: 10.1111/bjh.15720
Abstract: Bendamustine (B) with rituximab (R) is a standard frontline treatment for medically fit follicular lymphoma (FL) patients. The safety and efficacy of maintenance rituximab (MR) after BR induction has not been formally compared to observation… read more here.
Keywords: rituximab; maintenance rituximab; maintenance; follicular lymphoma ... See more keywords